Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Immunology/Inflammation related
    (7)
  • Apoptosis
    (4)
  • ADC Antibody
    (2)
  • Bcl-2 Family
    (2)
  • Bcl-6
    (2)
  • Integrin
    (2)
  • PROTACs
    (2)
  • Topoisomerase
    (2)
  • ADC Cytotoxin
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

non-hodgkin's lymphoma

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    24
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    11
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    3
    TargetMol | PROTAC
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Cell Research
    1
    TargetMol | Inhibitors_Agonists
PNU-159682
T16557202350-68-3
PNU-159682, a metabolite of anthracycline nemorubicin, is a DNA topoisomerase II inhibitor with excellent cytotoxicity.
  • $84
In Stock
Size
QTY
ARV-393
ARV393
T843162851885-95-3
ARV-393 is a PROTAC degrader targeting BCL6 with the advantage of being highly potent and orally available.ARV-393 recruits BCL6 and E3 ligase cerebellum to rapidly degrade BCL6 through the cell's natural ubiquitin proteasome system for the treatment of diffuse large b-cell lymphoma (DLBCL) and non-Hodgkin's lymphoma (NHL).
  • $223
In Stock
Size
QTY
E3 Ligase Ligand-linker Conjugate 170
T2051902379572-21-9
E3 Ligase Ligand-linker Conjugate 170 (Compound I) demonstrates antiproliferative activity in non-Hodgkin's lymphoma SU-DHL-4 cells, with an IC50 of less than 0.2 μM. This conjugate is composed of an E3 ligase ligand and a linker, making it suitable for use in PROTAC synthesis.
  • Inquiry Price
Size
QTY